Back
The Carlyle Group Vs. Janux Therapeutics Industry Stock Comparison
Buy
69
CG
The Carlyle Group
Last Price:
43.69
Seasonality Move:
0.72%
Sell
43
JANX
Janux Therapeutics
Last Price:
46.71
Seasonality Move:
8.69%
Buy
69
The Carlyle Group (CG)
is a Buy
Is The Carlyle Group a Buy, Sell or Hold?
- The current The Carlyle Group [CG] share price is $43.37. The Score for CG is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- CG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.99. The Score for JANX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CG Stock Price Chart
What is The Carlyle Group's stock price today?
-
The The Carlyle Group share price today is $43.37
The current trend is relatively stagnant and CG is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.99
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
CG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 48.62 | Sell |
| Chaikin Money Flow: | 271173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.76 - 45.34) | Sell |
| Bollinger Bands (100): | (40.87 - 46.41) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 46.13 | Sell |
| Chaikin Money Flow: | -166576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.56 - 57.74) | Sell |
| Bollinger Bands (100): | (12.73 - 49.75) | Buy |
CG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.85 | Buy |
| 20-day SMA: | 43.31 | Buy |
| 50-day SMA: | 45 | Sell |
| 200-day SMA: | 37.83 | Buy |
| 8-day EMA: | 42.99 | Buy |
| 20-day EMA: | 43.33 | Buy |
| 50-day EMA: | 43.94 | Sell |
| 200-day EMA: | 39.72 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.61 | Sell |
| 20-day SMA: | 52.95 | Sell |
| 50-day SMA: | 46.13 | Buy |
| 200-day SMA: | 20.35 | Buy |
| 8-day EMA: | 49.4 | Sell |
| 20-day EMA: | 50.62 | Sell |
| 50-day EMA: | 45.17 | Buy |
| 200-day EMA: | 26.75 | Buy |
The Carlyle Group Earnings Growth & CG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.13 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
The Carlyle Group Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||